Most MiNEN contain neuroendocrine cancer cells and adenocarcinoma cells. These cancers are often fast growing. The stage of a large bowel or rectal neuroendocrine cancer tells you about its size and ...

Patients with appendiceal adenocarcinoma have a 7.5% risk of second primary cancer within 10 years. There is a 12% excess incidence of secondary primary cancers, particularly colorectal, in these ...

The treatment you have depends on what type of neuroendocrine cancer you have. And it depends on where it is, its size and whether it has spread (the stage). These cancers grow at different rates. For ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the ...

rectal cancer, and merkel cell carcinoma (MCC). In its updated guidelines for colon cancer1 and for rectal cancer2, NCCN now includes ctDNA as a high risk factor for recurrence in the adjuvant ...